272 related articles for article (PubMed ID: 15340248)
1. Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats.
Soaje M; Bregonzio C; Carón RW; Deis RP
Neuroendocrinology; 2004; 80(1):11-20. PubMed ID: 15340248
[TBL] [Abstract][Full Text] [Related]
2. Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy.
Soaje M; Deis RP
Cell Mol Neurobiol; 2004 Apr; 24(2):193-204. PubMed ID: 15176435
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
4. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
5. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
6. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
8. Participation of the opioid system in the regulation of prolactin secretion in androgenized rats: effect of ovarian steroids.
Soaje M; Deis RP
Eur J Pharmacol; 1999 Apr; 371(1):43-9. PubMed ID: 10355593
[TBL] [Abstract][Full Text] [Related]
9. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
Kiritsy-Roy JA; Marson L; Van Loon GR
J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
[TBL] [Abstract][Full Text] [Related]
10. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
Schoffelmeer AN; Warden G; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1991 Jul; 258(1):237-42. PubMed ID: 1677039
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
Soaje M; Valdez S; Bregonzio C; Penissi A; Deis RP
Neuroendocrinology; 2006; 84(1):58-67. PubMed ID: 17090971
[TBL] [Abstract][Full Text] [Related]
12. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
13. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
14. Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons.
Koyama S; Akaike N
Neurosci Res; 2008 Jan; 60(1):22-8. PubMed ID: 17976846
[TBL] [Abstract][Full Text] [Related]
15. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
Shin MS; Helmstetter FJ
Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
[TBL] [Abstract][Full Text] [Related]
16. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
Churchill L; Kalivas PW
Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
[TBL] [Abstract][Full Text] [Related]
17. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
18. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
20. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
